Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://katrinamhcm043633.affiliatblogger.com/91127857/semaglutide-a-potential-solution-for-diabetes